Drugs / Covax-19
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04428073 | Jul 2020 → Jul 2021 | COVID-19 | GeneCure Biotechnologies | Unknown | No outcome recorded |
| Phase 1 | NCT04453852 | Jun 2020 → Feb 2021 | COVID-19 | Vaxine Pty Ltd | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Covax-19 | “This is a study to test a new vaccine (Covax-19) against COVID-19.” NCT04453852 ↗ |
| Modality | Vaccine | “Therapeutic vaccine for SARS-CoV-2 infection” NCT04428073 ↗ |
| Route | Intramuscular | “sterile solution for intramuscular injection” NCT04453852 ↗ |